Table 1 Antibiotic resistance according to source of isolates
Antibiotics | Sample Source (N=55) | P value | |||
|---|---|---|---|---|---|
Enviromental N = 32 | Healthcare Workers N = 14 | Clinical infections N = 9 | |||
Penicillin G (P) (10 µg) | N(%) | 32(100) | 14(100) | 9(100) |  |
Cefoxitin (CX) (30 µg) | N(%) | 23(71.9) | 13(92.9) | 8(88.9) | 0.201 |
Oxacillin (OX) (1 µg) | N(%) | 11(34.4) | 6(42.9) | 6(66.7) | 0.221 |
Erythromycin (E) (15 µg) | N(%) | 25(78.1) | 10(71.4) | 9(100.0) | 0.227 |
Clindamycin (CD) (2 µg) | N(%) | 6(18.8) | 4(28.6) | 7(77.8) | 0.003* |
Trimethoprim/ sulfamethoxazole (COT) (25 µg) | N(%) | 4(12.5) | 5(35.7) | 4(44.4) | 0.064 |
Ciprofloxacin (CIP) (5 µg) | N(%) | 3(9.4) | 3(21.4) | 4(44.4) | 0.051 |
Tetracycline (TE) (30 µg) | N(%) | 5(15.6) | 3(21.4) | 1(11.1) | 0.79 |
Rifampicin (RIF) (5 µg) | N(%) | 3(9.4) | 1(7.1) | 4(44.4) | 0.02* |
Gentamicin (GEN) (10 µg) | N(%) | 2(6.3) | 1(7.1) | 1(11.1) | 0.88 |
Cloramaphenicol (C) (30 µg) | N(%) | 2(6.3) | 0 | 0 | 0.5 |
Linezolid (LZ) (30 µg) | N(%) | 0 | 0 | 0 |  |
Teicoplanin (TEI) (30 µg) | N(%) | 3(9.4) | 0 | 0 | 0.32 |
Imipenem (IPM) (10 µg) | N(%) | 2(6.3%) | 1(7.1%) | 1(11.1%) |  |
Amoxicillin.clavulanic acid (AMC) (20/10 µg) | N(%) | 21(65.6) | 12(85.7) | 8(88.9) | 0.2 |
cefotaxime (CTX) (30 µg) | N(%) | 20(62.5) | 9(64.3) | 8(88.9) | 0.32 |